Cancer remains a significant global health challenge, with chronic inflammation often contributing in tumor development and progression. , As a result, the search for novel anti-inflammatory agents to complement conventional cancer therapies is essential. Triiptolide, a synthetic derivative of th

Barzolvolimab: A Promising Chance for Chronic Ailments? Barzolvolimab, a recently discovered medicinal compound, is creating considerable excitement within the scientific community. This innovative antibody functions as a powerful blocker of interleukin- 17F, a crucial driver in the